Pyridyl and thiazolyl bisamide CSF-1R inhibitors for the treatment of cancer.
The bisamide class of kinase inhibitors was identified as being active against CSF-1R. The synthesis and SAR of pyridyl and thiazolyl bisamides are reported, along with the pharmacokinetic properties and in vivo activity of selected examples.